Archived Press ReleasePress Release FDA Grants Premarket Approval (PMA) for the NeuroPace RNS® System to treat Medically Refractory Epilepsy — November 14, 2013 NeuroPace Inc.November 14, 2013
Archived Press ReleasePress Release FDA Advisory Panel Recommends Approval of the NeuroPace RNS® System for Medically Refractory Epilepsy — February 25, 2013 NeuroPace Inc.February 25, 2013
Archived Press ReleasePress Release NeuroPace Submits PMA Application for FDA Approval of Novel Investigational Device for Epilepsy — July 8, 2010 NeuroPace Inc.July 8, 2010
Archived Press ReleasePress Release Pivotal Trial Data Demonstrate NeuroPace RNS® System Reduced Seizures in People with Epilepsy — December 7, 2009 NeuroPace Inc.December 7, 2009
